A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AK0406 Injection in Healthy Adult Participants
Clinical trial NCT07432698 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07432698
- Sponsor
- Shanghai Ark Biopharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-01
- Primary completion
- 2027-04-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.